# A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

> **NCT05496361** · NA · COMPLETED · sponsor: **Suzhou Zenith Vascular Scitech Co., Ltd.** · enrollment: 238 (actual)

## Conditions studied

- AIS
- Acute Ischemic Stroke
- Large Vessel Occlusion
- Thrombectomy

## Interventions

- **DEVICE:** Tianyi Revascularization Device
- **DEVICE:** Solitaire FR Revascularization Device

## Key facts

- **NCT ID:** NCT05496361
- **Lead sponsor:** Suzhou Zenith Vascular Scitech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-24
- **Primary completion:** 2021-11-24
- **Final completion:** 2022-07-20
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05496361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05496361, "A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05496361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*